Compare AEXA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AEXA | LXRX |
|---|---|---|
| Founded | 2025 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 540.6M | 660.9M |
| IPO Year | N/A | 2000 |
| Metric | AEXA | LXRX |
|---|---|---|
| Price | $11.14 | $1.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.15 |
| AVG Volume (30 Days) | 75.4K | ★ 2.2M |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $49,803,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 60.24 |
| 52 Week Low | $10.49 | $0.49 |
| 52 Week High | $11.91 | $1.84 |
| Indicator | AEXA | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.62 | 64.34 |
| Support Level | $11.10 | $1.07 |
| Resistance Level | $11.30 | N/A |
| Average True Range (ATR) | 0.22 | 0.10 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 82.02 | 98.61 |
American Exceptionalism Acquisition Corp A is a blank check company.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.